Close Menu

Whitehead Institute

Broad Institute Founder Eric Lander outlined the past and future of cancer genome research this weekend at the American Association for Cancer Research meeting.

IP Roundup: Mar 10, 2009

Premium

Accelr8, Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Stanford University, Aperio Technologies

The cells, derived from patients with sporadic Parkinson's disease, remained pluripotent, and revealed a gene-expression profile that more closely resembled human embryonic stem cells than human iPS cells still carrying the reprogramming factors.

The deal brings to six the number of academic institutions from which Fate has licensed IP related to using small molecules to induce pluripotency in stem cells for therapeutic effect, drug discovery, and matched cell-replacement therapies.

People Transfer: Mar 4, 2009

Premium

Fate Therapeutics names Dan Shoemaker as CTO

Bruno Sobral, Michael Gilman, Kathy Gibson, Uwe Christians,Herbert Fritsche, Dan Crowther

Migrations: Feb 27, 2009

Premium

Rudolph Jaenisch, Feng Lin, Marilyn Panahi

Paired Ends: Feb 24, 2009

Premium

Roger Pettett, Richard Resnick

Funding from the National Institutes of Health for all proteomics-related research shrank by almost 3 percent in fiscal 2008, according to an analysis of NIH data by ProteoMonitor.

The researchers identified a link between genetic and environmental causes of Parkinson's in a yeast cell model, a finding that could validate a similar model developed at the Whitehead Institute and licensed to drug maker FoldRx.

Pages

Nebula Genomics will be auctioning George Church's genome as a nonfungible token, according to The Scientist.

Anthony Gregg, the outgoing president of the American College of Medical Genetics and Genomics, has resigned after using racially insensitive language. 

Facebook has developed an artificial intelligence approach to predict how drugs interact in cells, New Scientist reports.

In PNAS this week: adaptations among high-altitude Mycobacterium tuberculosis, response of multiple myeloma cells to chemotherapy-induced stress, and more.